Aβ42 oligomers selectively disrupt neuronal calcium release
Abstract Accumulation of amyloid-β (Aβ) peptides correlates with aging and progression of Alzheimer's disease (AD). Aβ peptides, which cause early synaptic dysfunctions, spine loss, and memory deficits, also disturb intracellular Ca2+ homeostasis. By cytosolic and endoplasmic reticulum Ca2+ mea...
Saved in:
Published in | Neurobiology of aging Vol. 36; no. 2; pp. 877 - 885 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract Accumulation of amyloid-β (Aβ) peptides correlates with aging and progression of Alzheimer's disease (AD). Aβ peptides, which cause early synaptic dysfunctions, spine loss, and memory deficits, also disturb intracellular Ca2+ homeostasis. By cytosolic and endoplasmic reticulum Ca2+ measurements, we here define the short-term effects of synthetic Aβ42 on neuronal Ca2+ dynamics. When applied acutely at submicromolar concentration, as either oligomers or monomers, Aβ42 did not cause Ca2+ release or Ca2+ influx. Similarly, 1-hour treatment with Aβ42 modified neither the resting cytosolic Ca2+ level nor the long-lasting Ca2+ influx caused by KCl-induced depolarization. In contrast, Aβ42 oligomers, but not monomers, significantly altered Ca2+ release from stores with opposite effects on inositol 1,4,5-trisphosphate (IP3 )- and caffeine-induced Ca2+ mobilization without alteration of the total store Ca2+ content. Ca2+ dysregulation by Aβ42 oligomers involves metabotropic glutamate receptor 5 and requires network activity and the intact exo-endocytotic machinery, being prevented by tetrodotoxin and tetanus toxin. These findings support the idea that Ca2+ store dysfunction is directly involved in Aβ42 neurotoxicity and represents a potential therapeutic target in AD-like dementia. |
---|---|
ISSN: | 0197-4580 1558-1497 |
DOI: | 10.1016/j.neurobiolaging.2014.10.020 |